top of page

Life Sciences
Gross to Net

Twelve Consulting Group Gross to Net Value Stream

GTN Modeling is a Differentiator for Life Sciences Companies

Life Sciences and Pharmaceutical manufacturers can use a consistent process across business functions and centralized, real-time data in a connected Anaplan model to more accurately forecast utilization and discounting by market segment, starting at the contract level.

 

By integrating gross-to-net management, manufacturers can quantitatively assess the amount of discounts flowing through each contract component and market segment, ultimately improving their ability to predict net revenue in future periods. This further enables improved accuracy of accruals and better-informed reserves, with potentially immediate impact on the bottom line.

Net Revenue Forecasting Challenges

Net Revenue Forecasting Challenges

Life Sciences & Pharmaceutical manufacturers find it difficult to forecast their net revenue because product pricing adjustments (discounts) to their gross revenue are highly complex, vary greatly across market segments and customers, and contain high-data volumes to process.

 

This difficulty in ability to forecast net sales directly impacts accrual management and product reserve accuracy. Moreover, due to the complexity and uniqueness of pricing adjustments, traditional spreadsheet-based approaches to forecasting lack scalability and are unable to incorporate interdependencies between market segments.

Anchor 1
noun_Checklist_1660423-01.png
noun_Checklist_1660423-01.png
noun_Checklist_1660423-01.png
noun_Checklist_1660423-01.png
noun_Checklist_1660423-01.png
noun_Checklist_1660423-01.png
noun_Checklist_1660423-01.png
noun_Checklist_1660423-01.png

Real-life collaboration 

Version management

Flexibility and configurability

High-data volumes across multiple market segments

 

Native audit trail 

Forecast accuracy 

A streamlined and centralized system

No disruption to upstream/downstream activities

Solution Benefits

Life sciences, pharma, challenges, solution benefits, gross to net
life sciences, pharma, customer story, pharma customer story

Gross to Net Demo Model

gross to net anaplan demo model
gross to net anaplan demo model
gross to net anaplan demo model

Learn how GTN modeling is a
Differentiator for Life Sciences Manufacturers!

RESOURCES

SPEAKING SESSION

WEBINAR

PDF

GTN Implementations: Best Practices, Purpose-Built Solutions and the Value of Automation.
Take a deep dive into how automation can streamline pre-deal analysis, GTN channel forecasting, and accruals management.
See how Gross to Net modeling is a differentiator for Pharma companies.
bottom of page